Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0HC3H
|
||||
| Former ID |
DNC012107
|
||||
| Drug Name |
Dimepheptanol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533539] | ||
| Formula |
C21H29NO
|
||||
| Canonical SMILES |
CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O
|
||||
| InChI |
1S/C21H29NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20,23H,5,16H2,1-4H3
|
||||
| InChIKey |
QIRAYNIFEOXSPW-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 545-90-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [533539] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [533539] | ||
| Kappa-type opioid receptor | Target Info | Inhibitor | [533539] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||